A CT-Based Clinical-Radiomics Nomogram for Predicting the Overall Survival to TACE Combined with Camrelizumab and Apatinib in Patients with Advanced Hepatocellular Carcinoma

This publication has 39 references indexed in Scilit:

• MRI‐Based Radiomics and Deep Learning in Biological Characteristics and Prognosis of Hepatocellular Carcinoma: Opportunities and Challenges
  Journal of Magnetic Resonance Imaging, 2023
• A CT-based radiomics nomogram for predicting the progression-free survival in small cell lung cancer: a multicenter cohort study
  La radiologia medica, 2023
• Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study
  European Radiology, 2023
• Delta radiomics: a systematic review
  La radiologia medica, 2021
• Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE
  European Radiology, 2021
• Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma
  Abdominal Radiology, 2019
• Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy
  Journal of Magnetic Resonance Imaging, 2017
• AASLD guidelines for the treatment of hepatocellular carcinoma
  Hepatology, 2017
• Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
  Statistics in Medicine, 2010
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
  Statistics in Medicine, 2007